Trials / Completed
CompletedNCT02813538
Major Liver Resection: Early Clotting Disorders and Functional Impairment.
Hypercoagulability and Liver Function After Major Liver Resection
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (actual)
- Sponsor
- Hospital General Universitario Gregorio Marañon · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to evaluate early clotting disorders through thromboelastogram and anticoagulant proteins levels (maybe also endothelial markers) and liver function by indocyanine green clearance after major liver resection and search for a potential relationship between them.
Detailed description
We are prospectively recording data from patients undergoing major liver resection. We obtain a full procoagulant and anticoagulant profile preoperatively and, at first, second and sixth day after surgery. We also measure indocyanine green (ICG) clearance preoperatively and in the first two postoperative days. We are also recording clinical data, focusing on medical and surgical complications. We aim to establish the potential value of ICG clearance and or coagulation profile to predict clinical complications
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Indocyanine green clearance | To evaluate liver function by injection of indocyanine green by a peripheral vein and measure its clearance |
| OTHER | Thromboelastometry | To evaluate blood coagulation impairment by obtaining blood sample from a peripheral vein and measure anticoagulant proteins levels plus obtaining thromboelastometry |
Timeline
- Start date
- 2016-02-05
- Primary completion
- 2018-10-01
- Completion
- 2019-04-01
- First posted
- 2016-06-27
- Last updated
- 2020-05-21
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT02813538. Inclusion in this directory is not an endorsement.